Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 106
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Parasitol Res ; 117(12): 3993-4002, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30302586

RESUMEN

The aim of the present study was to evaluate the effects of treatment with different anthelmintic compounds on the productivity of naturally infected calves and the economic viability of these treatments within extensive breeding systems employing different nutritional strategies after weaning. For this purpose, 4 farms with 42-60 calves naturally infected with gastrointestinal nematodes were selected. The calves were distributed into 6 groups (7-10 animals each) per farm and treated with ivermectin 1%, ivermectin 3.15%, eprinomectin 5%, levamisole 7.5%, albendazole 15%, and control group (no treatment). These animals were evaluated over an experimental period of 150 days. Levamisole 7.5% presented the best capacity for the reduction of eggs per gram (EPG) of feces in all herds evaluated, followed by albendazole 15% and eprinomectin 5%. Parasite resistance to multiple drugs was found in all herds, especially those of Cooperia, Haemonchus, Oesophagostomum, and Trichostrongylus. For farm 1, differences in weight gain and EPG reduction percentages led to a difference of US$285.06 between the levamisole and ivermectin 3.15% groups. Similar findings were noted for the levamisole and ivermectin 1% groups of farm 3, with a difference of US$399.37 because of the final weight gain in these groups. For farms 2 and 4, the ivermectin 3.15% and control groups, respectively, were the most profitable; these unexpected results were possibly influenced by variables not measured during the experimental period. This study suggested that anthelmintic treatments should always precede an efficacy test, once they are demonstrated to be most profitable under adequate breeding conditions, to ensure adequate control of gastrointestinal nematode infection.


Asunto(s)
Antihelmínticos/uso terapéutico , Enfermedades de los Bovinos/tratamiento farmacológico , Haemonchus/efectos de los fármacos , Infecciones por Nematodos/tratamiento farmacológico , Infecciones por Nematodos/veterinaria , Oesophagostomum/efectos de los fármacos , Carne Roja/parasitología , Trichostrongylus/efectos de los fármacos , Albendazol/uso terapéutico , Animales , Bovinos , Enfermedades de los Bovinos/parasitología , Heces/parasitología , Hemoncosis/tratamiento farmacológico , Hemoncosis/veterinaria , Ivermectina/análogos & derivados , Ivermectina/uso terapéutico , Levamisol/uso terapéutico , Esofagostomiasis/tratamiento farmacológico , Esofagostomiasis/veterinaria , Recuento de Huevos de Parásitos/veterinaria , Tricostrongiliasis/tratamiento farmacológico , Tricostrongiliasis/veterinaria , Destete
2.
Vet Parasitol ; 270: 1-6, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-31213235

RESUMEN

In 2016 suspected reduced ivermectin (IVM) efficacy in Oesophagostomum species in pigs was reported in England. Following this initial report, APHA raised awareness amongst private pig veterinary practitioners of the need to monitor the efficacy of the worm control on pig units. In 2017 another veterinary practitioner highlighted a potential in-field lack of IVM efficacy in treating Oesophagostomum species in sows on another breeder-finisher unit. In this trial, the efficacy of IVM against Oesophagostomum species worms has been investigated to determine whether suspected reduced efficacy (52% reduction in mean faecal egg count 14 days post ivermectin administration) on a mixed indoor and outdoor breeder-finisher pig farm in England reflected true IVM resistance under controlled experimental conditions. On days 0 and 40 of the trial, twenty helminth-naive pigs were artificially infected per os with 5000 Oesophagostomum L3 obtained from the farm under investigation. The pigs were allocated to treatment or control groups (n = 10 per group). Treatment group pigs received IVM (0.3 mg kg body weight) by sub-cutaneous injection as per manufacturer's instructions on day 44. Control group animals were left untreated. Faecal worm egg counts were monitored throughout the trial from day 15 post infection to determine time to patency. On day 50 all pigs were euthanased to assess the worm burdens. Resistance to IVM was confirmed in Oesophagostomum dentatum based on the results of a faecal egg count reduction test (FECRT) and a controlled efficacy test (CET). Efficacy based on mean reduction in faecal egg count of IVM-treated pigs compared to untreated control pigs was 86%. Mean reduction in IVM-treated pig worm burdens was 5% against an adult worm population and 94% against an L3/L4 population. The apparent discrepancy between FECRT and CET efficacy results appears to be due to egg development and/or oviposition suppression in IVM-treated female worms. The detection of IVM resistance in Oesophagostomum species worms for the first time in UK pigs is particularly important considering the global situation where resistance to pyrantel, levamisole and benzimidazole anthelmintics in Oesophagostomum species in pigs have already been reported. The results also provide an opportunity to discuss the wider issue of anthelmintic usage and efficacy on pig farms and highlight the need for wider surveillance for the occurrence of anthelmintic resistance in pigs.


Asunto(s)
Resistencia a Medicamentos , Ivermectina/farmacología , Esofagostomiasis/veterinaria , Oesophagostomum/efectos de los fármacos , Enfermedades de los Porcinos/parasitología , Animales , Antihelmínticos/administración & dosificación , Antihelmínticos/farmacología , Inglaterra , Heces/parasitología , Ivermectina/administración & dosificación , Esofagostomiasis/tratamiento farmacológico , Esofagostomiasis/parasitología , Recuento de Huevos de Parásitos , Porcinos , Enfermedades de los Porcinos/tratamiento farmacológico
3.
Vet Parasitol ; 146(3-4): 288-93, 2007 May 31.
Artículo en Inglés | MEDLINE | ID: mdl-17418952

RESUMEN

A study was conducted to evaluate and compare the efficacy of two injectable formulations of ivermectin (IVM-1 and IVM-2) at a dose rate of 0.3 mg/kg bodyweight versus placebo in the treatment and control of larval and adult stages of Ascaris suum and Oesophagostomum spp. in experimentally infected pigs. Seventy helminth free pigs were allocated on a liveweight basis to 7 groups each comprising 10 pigs (A-G). Group A served as an untreated control group. Groups B and C were used to investigate the efficacy of both formulations against adult stages of A. suum and Oesophagostomum spp., Groups D and E for efficacy against larval stages of A. suum and Groups F and G for efficacy against larval stages of Oesophagostomum spp. Pigs of groups A, B, C, D and E were infected on Day-0 with 1000 infective A. suum eggs each. Infective larvae of Oesophagostomum spp. (10,000/pig) were given on Day-0 to pigs of Groups F and G and on Day-21 to pigs of Groups A, B and C. Treatment was given to pigs of Group A (saline as placebo) on Day-7 and -28, IVM-1 to pigs of Group F on Day-7, pigs of Group D on Day-14 and pigs of Group B on Day-49. IVM-2 was given to pigs of Group G on Day-7, Group E on Day-28 and Group C on Day-49. Pigs of Groups F and G were sacrificed on Day-28, pigs of Groups A, D and E on Day-49 and pigs of Groups B and C on Day-56. Post mortem worm counts showed the following efficacies: (IVM-1) against larval A. suum 100%, against adult A. suum 94.4%, against larval Oesophagostomum spp. 52.0% and against adult Oesophagostomum spp. 83.0%. (IVM-2) against larval A. suum 100%, against adult A. suum 90.3%, against larval Oesophagostomum spp. 94.0% and against adult Oesophagostomum spp. 94.7%.


Asunto(s)
Antihelmínticos/uso terapéutico , Ascariasis/veterinaria , Ascaris suum/efectos de los fármacos , Ivermectina/uso terapéutico , Esofagostomiasis/veterinaria , Oesophagostomum/efectos de los fármacos , Enfermedades de los Porcinos/tratamiento farmacológico , Animales , Antihelmínticos/administración & dosificación , Ascariasis/tratamiento farmacológico , Femenino , Ivermectina/administración & dosificación , Larva/efectos de los fármacos , Masculino , Esofagostomiasis/tratamiento farmacológico , Porcinos , Enfermedades de los Porcinos/parasitología , Equivalencia Terapéutica
4.
Trans R Soc Trop Med Hyg ; 100(8): 760-6, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16730763

RESUMEN

Previous surveys conducted in northern Ghana where Oesophagostomum bifurcum is endemic showed that O. bifurcum-induced nodular pathology could be detected in up to 50% of the inhabitants. The impact of albendazole-based mass treatment to control both infection and morbidity is assessed and compared with the situation in a control area where no mass treatment has taken place. A significant reduction in the prevalence of infection based on stool cultures was achieved following two rounds of mass treatment in one year: from 52.6% (361/686) pre treatment to 5.2% (22/421) 1 year later (chi(1)(2)=210.1; P<0.001). At the same time, the morbidity marker of ultrasound-detectable nodules declined from 38.2% to 6.2% (chi(1)(2)=138.1; P<0.001). There was a shift from multinodular pathology, often seen in heavy infections, to uninodular lesions. In the control villages where no treatment took place, O. bifurcum infection increased from 17.8% (43/242) to 32.2% (39/121) (chi(1)(2)=9.6; P<0.001). Nodular pathology decreased slightly from 21.5% to 19.0%, but a higher proportion of these subjects developed multinodular pathology compared with baseline (chi(1)(2)=5.5; P=0.019). It is concluded that repeated albendazole treatment significantly reduces O. bifurcum-induced morbidity.


Asunto(s)
Albendazol/uso terapéutico , Antihelmínticos/uso terapéutico , Enfermedades Endémicas/prevención & control , Esofagostomiasis/tratamiento farmacológico , Adolescente , Adulto , Animales , Niño , Preescolar , Estudios Transversales , Heces/parasitología , Ghana/epidemiología , Humanos , Esofagostomiasis/epidemiología , Esofagostomiasis/prevención & control , Oesophagostomum/aislamiento & purificación , Prevalencia
5.
Int J Parasitol ; 27(4): 403-9, 1997 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9184932

RESUMEN

A dose-response study using fenbendazole (FBZ) was carried out in pigs infected with O. dentatum and O. quadrispinulatum to determine the minimum effective dose rate of the drug. Thirty pigs were randomly divided into 6 groups of 5 pigs and infected with 5000 infective larvae each. The animals were re-infected 5 days before treatment (Day 30 after the first infection) with the same number of larvae. On Day 35 the pigs in groups 1-5 were treated with FBZ at the following dose rates: 2.5 mg kg-1 (i.e. 50% of the registered dose level), 1.0 mg kg-1 (20%), 0.25 mg kg-1 (5%), 0.1 mg kg-1 (2%) and 0.05 mg kg-1 (1%), respectively. Pigs in group 6 served as non-treated controls. Seven days after treatment (Day 42 after infection) the pigs were slaughtered, worms recovered from the large intestine and counted. The species and sex of adult worms was determined. A high faecal egg count reduction (FECR) after treatment was observed in groups 1, 2 and 3 (98%, 88% and 91%, respectively), while in groups 4 and 5 the egg counts were not affected by treatment. The mean worm count reduction was high in groups 1, 2 and 3 (100%, 99.9% and 98.6%, respectively), but declined in groups 4 and 5 (77% and 40%, respectively). FBZ showed a high efficacy against immature worms in groups 1 and 2, while in groups 3, 4 and 5 counts were not reduced. Species differentiation revealed a higher effect of FBZ against O. dentatum than against O. quadrispinulatum. Sex differentiation indicated a slightly higher (not significant) efficacy against females than males in both species. This study demonstrated a high efficacy of FBZ against the nodular worms in pigs, even at 5% of the currently registered dose level.


Asunto(s)
Antinematodos/uso terapéutico , Fenbendazol/uso terapéutico , Esofagostomiasis/veterinaria , Enfermedades de los Porcinos/tratamiento farmacológico , Animales , Relación Dosis-Respuesta a Droga , Femenino , Masculino , Esofagostomiasis/tratamiento farmacológico , Esofagostomiasis/parasitología , Recuento de Huevos de Parásitos , Porcinos , Enfermedades de los Porcinos/parasitología
6.
Int J Parasitol ; 26(4): 369-74, 1996 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8773524

RESUMEN

Anthelmintic efficacies of 3 different doses of ivermectin (IVM) were evaluated in 3 isolates of nodular worms in pigs. An isolate of Oesophagostomum quadrispinulatum (OQ) was recently obtained from a commercial farm where poor efficacy of IVM at the recommended dose (300 micrograms.kg-1 body weight) was detected. On this farm, IVM had been used for treatment of sows twice yearly for 6 years. Two other isolates, an O. dentatum (OD) and a mixed Oesophagostomum dentatum and Oesophagostomum quadrispinulatum isolate (ODQ) were obtained from a farm where anthelmintics had never been used. Efficacies of IVM against adult worms of the OQ-isolate at dose rates of 150, 300 and 600 micrograms.kg-1 body weight ranged from 40.5-78.6%. Efficacies against larval stages (L3 and L4) were superior. Efficacies against the OD-isolate were 88.7, 96.1 and 99.6%, respectively. In the ODQ-isolate the efficacies of IVM against adult stages furnished similar results. In conclusion, the efficacy of IVM against O. dentatum was high but against both isolates of O. quadrispinulatum poorer. This suggests that IVM is intrinsically less effective against O. quadrispinulatum and therefore not indicative of acquisition of anthelmintic resistance in the OQ-isolate.


Asunto(s)
Antihelmínticos/uso terapéutico , Ivermectina/uso terapéutico , Esofagostomiasis/veterinaria , Oesophagostomum/aislamiento & purificación , Enfermedades de los Porcinos , Animales , Relación Dosis-Respuesta a Droga , Heces/parasitología , Femenino , Larva , Masculino , Esofagostomiasis/tratamiento farmacológico , Oesophagostomum/efectos de los fármacos , Oesophagostomum/crecimiento & desarrollo , Recuento de Huevos de Parásitos , Porcinos
7.
Int J Parasitol ; 26(12): 1375-80, 1996 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-9024887

RESUMEN

The pharmacokinetic disposition of pyrantel after intravenous (i.v.) and oral (p.o.) administration as the citrate and p.o. administration as the pamoate salt was determined in pigs. Following i.v. administration pyrantel was quickly cleared from the bloodstream, exhibiting a terminal half-life of 1.75 +/- 0.19 h and a residence time (MRT) of 2.54 +/- 0.27 h. After p.o. administration as the citrate salt, the absorption time (MAT) of pyrantel was 2.38 +/- 0.25 h and although significant quantities of pyrantel were absorbed (mean bioavailability of 41%) the rapid clearance resulted in a MRT of only 4.92 +/- 0.36 h. By comparison, the significantly extended MAT of the less soluble pamoate salt resulted in reduced circulating concentrations and a significantly lower mean bioavailability of 16%. The poor efficacy of pyrantel citrate against nematodes inhabiting the large intestine of pigs is therefore suggested to result from insufficient quantities of drug passaging to the site of infection. When tested against pyrantel-resistant adult Oesophagostomum dentatum the mean efficacy of pyrantel citrate was only 23%, whereas the efficacy of the lesser absorbed pyrantel pamoate was 75%. These results indicate that for maximum activity pyrantel should be administered to pigs as the pamoate salt.


Asunto(s)
Antinematodos/farmacocinética , Esofagostomiasis/veterinaria , Pamoato de Pirantel/farmacocinética , Pirantel/análogos & derivados , Pirantel/uso terapéutico , Enfermedades de los Porcinos , Administración Oral , Animales , Antinematodos/administración & dosificación , Antinematodos/uso terapéutico , Disponibilidad Biológica , Resistencia a Medicamentos , Femenino , Semivida , Inyecciones Intravenosas , Cinética , Masculino , Tasa de Depuración Metabólica , Esofagostomiasis/tratamiento farmacológico , Oesophagostomum/aislamiento & purificación , Pirantel/administración & dosificación , Pirantel/farmacocinética , Pamoato de Pirantel/administración & dosificación , Pamoato de Pirantel/uso terapéutico , Porcinos
8.
Int J Parasitol ; 27(12): 1523-9, 1997 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-9467737

RESUMEN

An in vivo study evaluated the effect of diet on the efficacy of piperazine against nodular worms of pigs. Twenty pigs, later allocated into five groups, were each infected (and 37 days later re-infected) with 3000 infective larvae of a mixed isolate of Oesophagostomum dentatum and Oesophagostomum quadrispinulatum. Beginning on day 23 post infection (p.i.), pigs in groups 1 and 2 were fed a low-fibre diet consisting of 70% barley flour and 30% protein concentrate, while pigs in groups 3, 4 and 5 were fed a high-fibre diet consisting of 55% barley flour, 21% oat-husk meal and 24% protein concentrate. On day 42 p.i., pigs in groups 1 and 3 were orally dosed with 200 mg piperazine dihydrochloride (Ascarex D, 53%) per kg bodyweight, the recommended dose, while pigs in group 4 were given 100 mg kg-1. Groups 2 and 5 served as non-treated controls for the respective dietary regimens. Eight days after treatment, the pigs were slaughtered and worms recovered from the caecum and large intestine (divided into five sections) and counted. The mean worm count reduction (WCR) in group 1 (full-dose piperazine with low-fibre diet) was 89.8%, while the high-fibre diet in group 3 increased the WCR to 99.4%. In group 4, where the pigs were fed the high-fibre diet and treated with only 100 mg piperazine kg-1, the WCR was 90.9%, identical to the "low fibre" group 1 treated with twice this piperazine dose. There was a zero efficacy recorded against immature worms in all three treated groups. The high-fibre diet improved the efficacy of piperazine against more pathogenic and generally more tolerant O. quadrispinulatum to 99.2% compared with 84.3% at the low-fibre diet.


Asunto(s)
Antinematodos/farmacología , Fibras de la Dieta/administración & dosificación , Parasitosis Intestinales/veterinaria , Esofagostomiasis/veterinaria , Oesophagostomum/efectos de los fármacos , Piperazinas/farmacología , Enfermedades de los Porcinos/parasitología , Animales , Antinematodos/uso terapéutico , Relación Dosis-Respuesta a Droga , Parasitosis Intestinales/tratamiento farmacológico , Parasitosis Intestinales/parasitología , Esofagostomiasis/tratamiento farmacológico , Esofagostomiasis/parasitología , Recuento de Huevos de Parásitos , Piperazina , Piperazinas/uso terapéutico , Porcinos/parasitología , Enfermedades de los Porcinos/tratamiento farmacológico
9.
Am J Trop Med Hyg ; 46(4): 469-72, 1992 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-1575294

RESUMEN

In northern Togo and northeastern Ghana, Oesophagostomum bifurcum is a common parasite in humans. Diagnosis is based on coproculture because the eggs of hookworm and Oesophagostomum are indistinguishable. To determine the level of egg production, 12 subjects were treated with 2 x 10 mg/kg of pyrantel pamoate and the worms they evacuated were then counted. Pretreatment and post-treatment species-specific egg counts were calculated on the basis of larval and total egg counts. The median worm burden was 81 (range 12-300) per person. The calculated median egg production was 33.7 egg/gram of feces per female worm. Assuming a total daily stool production of 150 g/day, this amounts to 5,055 eggs/day, which is comparable with the production of other nematodes of the same superfamily.


Asunto(s)
Esofagostomiasis/parasitología , Oesophagostomum/fisiología , Oviposición , Ancylostomatoidea/aislamiento & purificación , Animales , Catárticos/uso terapéutico , Heces/parasitología , Femenino , Humanos , Larva/aislamiento & purificación , Esofagostomiasis/tratamiento farmacológico , Oesophagostomum/aislamiento & purificación , Recuento de Huevos de Parásitos , Pamoato de Pirantel/uso terapéutico , Togo
10.
Trans R Soc Trop Med Hyg ; 87(1): 87-9, 1993.
Artículo en Inglés | MEDLINE | ID: mdl-8465409

RESUMEN

Oesophagostomum bifurcum has recently been recognized as a common parasite of man in northern Togo and in Ghana. In a preliminary trial several anthelmintics were evaluated in the treatment of mixed Oesophagostomum and hookworm infections. Diagnosis was based on faecal culture, since the eggs of Oesophagostomum and hookworm cannot be distinguished morphologically. Of the anthelmintics tested, albendazole was most effective against both parasites. Pyrantel pamoate, 2 x 10 mg/kg, was effective against Oesophagostomum but not against hookworm. The cure rates for both parasites were moderate with thiabendazole and poor with levamisole.


Asunto(s)
Albendazol/uso terapéutico , Infecciones por Uncinaria/tratamiento farmacológico , Levamisol/uso terapéutico , Esofagostomiasis/tratamiento farmacológico , Pamoato de Pirantel/uso terapéutico , Tiabendazol/uso terapéutico , Animales , Relación Dosis-Respuesta a Droga , Heces/parasitología , Femenino , Infecciones por Uncinaria/parasitología , Humanos , Masculino , Esofagostomiasis/parasitología , Recuento de Huevos de Parásitos , Togo , Resultado del Tratamiento
11.
Vet Parasitol ; 31(3-4): 259-67, 1989 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-2527434

RESUMEN

This study was undertaken to determine the level of resistance against pyrantel citrate in strains of Oesophagostomum quadrispinulatum and Oesophagostomum dentatum which have previously been found resistant to this anthelmintic. Groups of pigs were artificially infected with batches of infective larvae which were previously found either susceptible or resistant to pyrantel citrate. After treatment with 1, 2 and 4 times the recommended dose (14 mg kg-1) of pyrantel citrate, the resistant O. quadrispinulatum population was reduced by 51.0, 76.2 and 86.1%, and O. dentatum by 41.2, 47.9 and 78.5%. The results indicated that O. dentatum was slightly more resistant (P less than 0.05) than O. quadrispinulatum to pyrantel citrate. Treatment of the susceptible worms with 1 and 2 times the recommended dose caused a reduction in worm numbers by 61.0 and 99.4%, respectively.


Asunto(s)
Esofagostomiasis/veterinaria , Pirantel/uso terapéutico , Enfermedades de los Porcinos/tratamiento farmacológico , Animales , Relación Dosis-Respuesta a Droga , Resistencia a Medicamentos , Femenino , Masculino , Esofagostomiasis/tratamiento farmacológico , Recuento de Huevos de Parásitos/veterinaria , Factores Sexuales , Organismos Libres de Patógenos Específicos , Porcinos , Enfermedades de los Porcinos/parasitología
12.
Vet Parasitol ; 103(1-2): 89-97, 2002 Jan 03.
Artículo en Inglés | MEDLINE | ID: mdl-11751004

RESUMEN

Two controlled tests were performed to investigate the benzimidazole resistance of a nodular worm isolate "GIBZ" from a pig breeding farm in Germany. In Trial I, groups of five pigs, artificially infected with Oesophagostomum larvae isolated from that farm were treated with flubendazole at a single dose of 5 mg kg(-1) bodyweight (BW) or remained untreated. In Trial II, three groups of three pigs each infected with larvae after a further laboratory passage of this isolate were treated with flubendazole either at a single dose of 5 mg kg(-1) BW or at a divided dose of 1.5 mg kg(-1) BW daily for 5 consecutive days, or with fenbendazole at a single dose of 5 mg kg(-1) BW, the fourth infected group remained untreated. The respective doses of anthelmintics were mixed with a small amount of feed and administered to individual pigs in both trials. Fecal egg counts before and after treatment and post-mortem worm burdens 7 days after (last) treatment were examined to assess the anthelmintic efficacies. Only infections with Oesophagostomum dentatum were found in both trials. In Trial I, the mean worm count reduction by flubendazole was 30% as compared to the untreated controls. In Trial II, flubendazole administered at a single or divided dose reduced the mean worm burden by 0 and 85%, respectively, whereas fenbendazole was 100% effective. These results establish resistance to flubendazole in the isolate "GIBZ" of O. dentatum. The failure to reveal side resistance to fenbendazole may be explained by that the currently recommended dose rate of this compound is supra-optimal for porcine nodular worms.


Asunto(s)
Antinematodos/farmacología , Mebendazol/análogos & derivados , Mebendazol/farmacología , Esofagostomiasis/veterinaria , Oesophagostomum/efectos de los fármacos , Enfermedades de los Porcinos/tratamiento farmacológico , Animales , Antinematodos/uso terapéutico , Relación Dosis-Respuesta a Droga , Resistencia a Medicamentos , Heces/parasitología , Femenino , Alemania , Masculino , Mebendazol/uso terapéutico , Esofagostomiasis/tratamiento farmacológico , Recuento de Huevos de Parásitos/veterinaria , Pruebas de Sensibilidad Parasitaria/veterinaria , Distribución Aleatoria , Porcinos , Enfermedades de los Porcinos/parasitología , Resultado del Tratamiento
13.
Vet Parasitol ; 96(2): 135-46, 2001 Mar 20.
Artículo en Inglés | MEDLINE | ID: mdl-11230920

RESUMEN

The helminth infections on 13 pig fattening farms with different management systems (complete or partial all-in-all-out system or continuous fattening) in North-Western Germany were investigated over at least three fattening periods. Pooled faecal samples were taken from pens once before and three times after anthelmintic treatment. At the beginning of fattening 34.9% of the samples contained helminth eggs, mainly from Oesophagostomum spp. (27.5%). Ascaris suum eggs were found in 10.5% of the samples, while other parasites were only rarely found. The number of pig-supplying farms was positively correlated with the helminth infection prevalence. Immediately after deworming, all pen samples were free of helminth eggs. However, the prevalences increased again, and by the end of fattening A. suum was found in 33.0% and strongylids in 6.0% of the samples. Pens harbouring A. suum-excreting pigs at the beginning of fattening had higher infection levels at the end, and this was also the case for nodular worms. The final prevalence of Ascaris was higher in partial exchange systems than in complete all-in-all-out systems and in old pig houses compared to new ones. Transmission of both Ascaris and Oesophagostomum was highest in autumn and winter. Thus, a single anthelmintic treatment at the beginning of fattening could not prevent infection during fattening, and the state of infection at the beginning was associated with the helminth burden at slaughter. Therefore, the purchase of parasite-free pigs in combination with appropriate hygiene management may minimise the initial infection pressure and keep subsequent infection of the herd at a minimum.


Asunto(s)
Crianza de Animales Domésticos , Esofagostomiasis/veterinaria , Enfermedades de los Porcinos/epidemiología , Porcinos/parasitología , Tricuriasis/veterinaria , Crianza de Animales Domésticos/métodos , Animales , Antihelmínticos/uso terapéutico , Alemania/epidemiología , Vivienda para Animales , Esofagostomiasis/tratamiento farmacológico , Esofagostomiasis/epidemiología , Oesophagostomum , Recuento de Huevos de Parásitos/veterinaria , Enfermedades de los Porcinos/tratamiento farmacológico , Tricuriasis/tratamiento farmacológico , Tricuriasis/epidemiología , Trichuris
14.
Vet Parasitol ; 68(1-2): 127-42, 1997 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9066059

RESUMEN

The results of four alternative methods of mean faecal egg count reduction percentage (FECR%) calculations were evaluated and compared using data obtained for Oesophagostomum spp. from ten sow herds. The estimates of FECR% and 95% confidence limits obtained using the four methods were different. However, there were few discrepancies in the final decision as to whether a given herd carried drug resistant isolates or not. The methods that used geometric means were more appropriate than those that used the arithmetic mean as the measure of central tendency for eggs per gram of faeces (EPG) values. The use of geometric mean EPG values in calculations has been criticized from several viewpoints, one of which is that its use reduces the comparability of reports between laboratories. If the geometric mean is to be used as we suggest in FECR% calculations, the appropriate references, number of animals in each group, minimum and maximum EPG values and the factor added to zero EPG counts should be reported in order to improve the comparability. The difficulty in obtaining groups with similar pre-treatment EPG values in field situations suggested the inclusion of pre-treatment EPG values in the calculations as an adjustment procedure. The importance of including a non-treated control group in calculations was demonstrated during this study. Therefore, we suggest the use of geometric mean EPG values, to include pre-treatment EPG values and to include the egg counts from the control group in FECR% calculations. The interpretation of the resulting FECR estimate may be different according to the purpose for which the testing procedure is carried out, e.g. survey in detecting anthelmintic resistance, control field tests, etc.


Asunto(s)
Antihelmínticos/uso terapéutico , Resistencia a Medicamentos , Heces/parasitología , Esofagostomiasis/veterinaria , Oesophagostomum/efectos de los fármacos , Recuento de Huevos de Parásitos , Enfermedades de los Porcinos , Animales , Antihelmínticos/toxicidad , Intervalos de Confianza , Femenino , Ivermectina/uso terapéutico , Levamisol/uso terapéutico , Mebendazol/análogos & derivados , Mebendazol/uso terapéutico , Modelos Estadísticos , Esofagostomiasis/tratamiento farmacológico , Oesophagostomum/aislamiento & purificación , Recuento de Huevos de Parásitos/veterinaria , Piperazina , Piperazinas/uso terapéutico , Pirantel/uso terapéutico , Porcinos
15.
Vet Parasitol ; 24(3-4): 229-39, 1987 May.
Artículo en Inglés | MEDLINE | ID: mdl-2956755

RESUMEN

This study was undertaken to determine whether anthelmintic-resistant Oesophagostomum spp. populations occur in Danish swine herds. A controlled field trial on selected sow herds suggested resistance to pyrantel citrate in a herd where faecal egg count depression in response to treatment was only 28.3%. This was confirmed by subsequent experimental infection of pigs where the suspected resistant Oesophagostomum isolate was compared with a susceptible worm isolate. After treatment with the recommended dose of the drug, worm burdens of the suspected isolate were only reduced by 42.6% (p greater than 0.05) in contrast to the susceptible isolate, which was reduced by 94.6% (p less than 0.01). Differential counts of the resistant isolate suggested that O. dentatum might be more resistant than O. quadrispinulatum. The resistant isolate originated from a herd, where the anthelmintic had been administered four times a year over a period of 7 years. The potential for development of anthelmintic resistance in Oesophagostomum spp. under management practices in our country is discussed in the light of the current views on predisposing factors.


Asunto(s)
Esofagostomiasis/veterinaria , Oesophagostomum/efectos de los fármacos , Pirantel/farmacología , Enfermedades de los Porcinos/tratamiento farmacológico , Animales , Resistencia a Medicamentos , Heces/parasitología , Femenino , Vivienda para Animales , Masculino , Esofagostomiasis/tratamiento farmacológico , Recuento de Huevos de Parásitos/veterinaria , Embarazo , Complicaciones Infecciosas del Embarazo/tratamiento farmacológico , Complicaciones Infecciosas del Embarazo/veterinaria , Pirantel/uso terapéutico , Organismos Libres de Patógenos Específicos , Porcinos
16.
Vet Parasitol ; 80(2): 159-66, 1998 Dec 31.
Artículo en Inglés | MEDLINE | ID: mdl-9870368

RESUMEN

The uptake of 14C-glucose by adult Oesophagostomum dentatum was characterised. The uptake was a non-linear function of external glucose concentration. The maximum velocity of uptake (Vmax) was 0.964 nmol/100 mg dry weight (dw)/5 min, and the transport constant (Kt) was 10.02 microM. When phlorizin, phloretin and 3-O-methylglucose were tested for their effects on the uptake of 14C-glucose, phloretin and 3-O-methylglucose produced significant inhibitions, indicating that the uptake was mediated and occurred by facilitated diffusion. Exposure of the worms to oxfendazole prior to incubation with 14C-glucose did not affect the uptake of glucose. In another experiment worms were incubated with unlabelled glucose and the external glucose concentration was measured enzymatically. During a 7 h incubation period, the quantity of glucose remaining in the incubation medium of oxfendazole exposed worms was significantly greater than in the control group. It was concluded that oxfendazole did not influence the process of 14C-glucose uptake, but might induce changes in the parasite leading to a reduced ability to deplete the incubation medium of glucose.


Asunto(s)
Antihelmínticos/farmacología , Bencimidazoles/farmacología , Glucosa/metabolismo , Oesophagostomum/metabolismo , 3-O-Metilglucosa/farmacología , Animales , Antihelmínticos/uso terapéutico , Bencimidazoles/uso terapéutico , Femenino , Esofagostomiasis/tratamiento farmacológico , Esofagostomiasis/parasitología , Oesophagostomum/efectos de los fármacos , Recuento de Huevos de Parásitos/veterinaria , Floretina/farmacología , Florizina/farmacología , Análisis de Regresión , Conteo por Cintilación/veterinaria , Porcinos
17.
Vet Parasitol ; 36(3-4): 245-57, 1990 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-2144677

RESUMEN

During 1982-1984, the occurrence of helminths in 66 sow herds in Denmark was examined by means of faecal samples. The correlations between the prevalences of Ascaris suum and Oesophagostomum spp. and management practices were analysed for fatteners and sows, respectively, resulting in four multivariate models. The helminth prevalences were in general low in large herds, specific pathogen-free (SPF) herds and herds with low weaning age. The multivariate analyses showed that only the two latter correlations were significant. The helminth prevalences of the fatteners were not correlated with anthelmintic treatment. In the sows, anthelmintic treatment was significantly correlated with low prevalences of both helminths, despite samples from recently dewormed sows indicating a rather transitory effect. The prevalences of Oesophagostomum in both fatteners and sows were significantly higher on solid floors with straw bedding than on slatted floors without straw, while this was not the case for Ascaris. Tethering of sows was not significantly correlated with helminth prevalences. Daily cleaning was significantly correlated with low helminth prevalences in fatteners, but not in the sows, while disinfection of the pens was only significantly correlated with low prevalences of Oesophagostomum in fatteners. No correlations to washing of the pens were found. The epidemiology of Ascaris and Oesophagostomum is discussed, especially why the latter is the most sensitive to intensive management.


Asunto(s)
Crianza de Animales Domésticos , Antihelmínticos/uso terapéutico , Ascariasis/veterinaria , Esofagostomiasis/veterinaria , Complicaciones Infecciosas del Embarazo/veterinaria , Enfermedades de los Porcinos/epidemiología , Animales , Ascariasis/tratamiento farmacológico , Ascariasis/epidemiología , Dinamarca/epidemiología , Femenino , Lactancia , Análisis Multivariante , Esofagostomiasis/tratamiento farmacológico , Esofagostomiasis/epidemiología , Recuento de Huevos de Parásitos/veterinaria , Embarazo , Complicaciones Infecciosas del Embarazo/tratamiento farmacológico , Complicaciones Infecciosas del Embarazo/epidemiología , Prevalencia , Organismos Libres de Patógenos Específicos , Porcinos , Enfermedades de los Porcinos/tratamiento farmacológico , Destete
18.
Vet Parasitol ; 108(1): 75-83, 2002 Aug 30.
Artículo en Inglés | MEDLINE | ID: mdl-12191901

RESUMEN

Separate controlled trials were conducted to evaluate the efficacy of two formulations of moxidectin (1% non-aqueous injectable solution and 0.5% pour-on (Cydectin) against larval or adult stages of Oesophagostomum radiatum and Trichuris discolor infecting cattle. Fifty-three strongylate-free dairy breed steer calves were obtained from commercial sources. After a brief acclimation period, calves were randomly divided into two pools to evaluate the efficacy of the moxidectin formulations against targeted larval (n = 27 calves) or adult (n = 26 calves) parasites. Calves in the larvacidal trial were inoculated on Day -16 relative to treatment with approximately 1000 embryonated Trichuris spp. eggs and approximately 640 infective Oesophagostomum spp. larvae. Calves were allocated by lottery to one of three treatment groups (n = 8 per group), which included: Group 1--moxidectin 0.5% pour-on (0.5 mg/kg body weight (BW)) applied topically; Group 2--moxidectin 1% non-aqueous injectable (0.2 mg/kg BW) administered subcutaneously; Group 3--untreated controls. Treatments were administered on Day 0 and calves were housed by group with no contact among animals of different treatments. Three sentinel calves were necropsied on Day 0 of the larvacidal trial to assess viability of larval inocula. On Days 14, 15 and 16 after treatment, calves were euthanatized (two or three from each group per day) and samples of gut contents were collected for determination of total worm counts. On Day -63 relative to treatment, calves in the adulticidal efficacy trial were inoculated with approximately 1000 embryonated Trichuris eggs and then on Day -35 with approximately 2500 infective Oesophagostomum spp. larvae. Fecal samples were collected on Day -7 and the 24 calves with the highest egg counts were assigned by lottery to the following three treatment groups (n = 8 per group): Group 4--moxidectin 0.5% pour-on; Group 5--moxidectin 1% injectable; Group 6--untreated controls. Details of experimental treatments, calf housing and necropsy scheduling were similar to the larvacidal trial. In both the larvacidal and adulticidal trials, inocula contained a variety of parasites in addition to the targeted species. Based on geometric means, both moxidectin 0.5% pour-on and moxidectin 1% non-aqueous injectable significantly reduced (P < 0.05) numbers of Oesophagostomum spp. and Trichuris spp. with anthelmintic efficacies of >99% when used against adult or larval stages of infection. In addition, both formulations of moxidectin demonstrated >95% efficacy (P < 0.05) against larval stages of Strongyloides papillosus. The pour-on formulation had >97% adulticidal and larvacidal efficacy against Cooperia spp. females, while the injectable product was effective against female Cooperia spp. larvae and Cooperia oncophora adult males.


Asunto(s)
Antihelmínticos/uso terapéutico , Antibacterianos/uso terapéutico , Enfermedades de los Bovinos/tratamiento farmacológico , Esofagostomiasis/veterinaria , Tricuriasis/veterinaria , Administración Tópica , Animales , Antihelmínticos/administración & dosificación , Antibacterianos/administración & dosificación , Bovinos , Enfermedades de los Bovinos/parasitología , Relación Dosis-Respuesta a Droga , Heces/parasitología , Inyecciones Subcutáneas/veterinaria , Larva/efectos de los fármacos , Larva/crecimiento & desarrollo , Macrólidos , Masculino , Esofagostomiasis/tratamiento farmacológico , Oesophagostomum/efectos de los fármacos , Oesophagostomum/crecimiento & desarrollo , Recuento de Huevos de Parásitos/veterinaria , Resultado del Tratamiento , Tricuriasis/tratamiento farmacológico , Trichuris/efectos de los fármacos , Trichuris/crecimiento & desarrollo
19.
Vet Parasitol ; 40(3-4): 273-9, 1991 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-1788934

RESUMEN

The efficacy of intraruminal albendazole (ABZ) capsules (Profitril-Captec) and the effect of treatment on productivity were studied in 300 ewes infected with gastrointestinal nematodes and the trematode Dicrocoelium dendriticum. Coprological tests revealed that treated animals remained negative for 10 weeks after the administration of capsules. Contamination of pasture with nematode larvae was significantly reduced during the whole experiment. Necropsy of 14 animals (seven treated and seven untreated) showed 96.9-99.2% efficacy against the nematodes Nematodirus spp., Oesophagostomum spp., Cooperia spp., Trichostrongylus spp. and Trichuris ovis, while efficacy was 88.5% against D. dendriticum. During the 6 month pasture season (May-October 1989), treated ewes produced on average 2.56 kg cheese and 0.6 kg wool per ewe more than untreated controls. Our study confirms the reliability of the ABZ slow-release capsules over 90 days and the positive effect of treatment on nematode contamination of pasture and ewe productivity.


Asunto(s)
Albendazol/administración & dosificación , Nematodos/efectos de los fármacos , Infecciones por Nematodos/veterinaria , Enfermedades de las Ovejas/parasitología , Albendazol/uso terapéutico , Animales , Cápsulas , Queso , Preparaciones de Acción Retardada , Heces/parasitología , Femenino , Infecciones por Nematodos/tratamiento farmacológico , Infecciones por Nematodos/parasitología , Esofagostomiasis/tratamiento farmacológico , Esofagostomiasis/parasitología , Esofagostomiasis/veterinaria , Oesophagostomum/efectos de los fármacos , Recuento de Huevos de Parásitos/veterinaria , Ovinos , Enfermedades de las Ovejas/tratamiento farmacológico , Tricostrongiliasis/tratamiento farmacológico , Tricostrongiliasis/parasitología , Tricostrongiliasis/veterinaria , Trichostrongylus/efectos de los fármacos , Tricuriasis/tratamiento farmacológico , Tricuriasis/parasitología , Tricuriasis/veterinaria , Trichuris/efectos de los fármacos , Lana
20.
Vet Parasitol ; 87(1): 39-44, 1999 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-10628698

RESUMEN

Forty pigs with induced infections of Ascaris suum, Trichuris suis, Metastrongylus spp., Oesophagostomum dentatum and O. quadrispinulatum were assigned to five-dose groups of moxidectin 0.5% pour-on with eight pigs per dose group. The doses were: moxidectin, 0 (vehicle control), 0.75, 1.00, 1.25, and 1.50 mg/kg(-1) body weight. Worm egg counts (EPG) were made from fecal samples collected on Day 2 pretreatment and on Day 14 or 15 post-treatment. Animals were ranked according to the descending order of A. suum egg counts made on Day 2 and blocked in groups of five. Pigs in blocked groups were assigned randomly to each of the five dose groups. Treatment doses were calculated on the basis of weights taken on Day 1 and were administered topically from the neck to the base of the tail. Pigs were housed by pairs in individual pens provided with self-feeders and automatic waterers. Necropsies were performed on equal numbers of pigs from each treatment group on days 14 and 15 post-treatment. Adult and larval worms were collected, identified and counted by standard parasitological techniques. All counts were transformed by Y=log10 (count+1) transformation prior to analysis. A two-way analysis of variance was conducted and treatment effect was tested for significance at the 5% level. Efficacies based on geometric means and optimal doses were as follows: Ascaris suum, 98.3% at 1.25; Metastrongylus spp., 100% at 0.75; Oesophagostomum quadrispinulatum, 100% at 1.50; and Trichuris suis, 93.5% at 0.75. Efficacy for O. dentatum was from 81.3% to 100%; however, the average number of O. dentatum (30) was too small for significance. Two species of lungworms were present, Metastrongylus apri and M. pudendotectus but they were not speciated at necropsy. As reported for several anthelmintics, the efficacy of moxidectin was variable for Trichuris. The highest efficacy was in the 0.75 dose group with six pigs harboring a few or no worms. The lowest efficacy was in the 1.25 group with only two pigs harboring a few or no worms.


Asunto(s)
Antihelmínticos/farmacología , Nematodos/efectos de los fármacos , Infecciones por Nematodos/veterinaria , Enfermedades de los Porcinos/tratamiento farmacológico , Animales , Antihelmínticos/administración & dosificación , Antihelmínticos/uso terapéutico , Antibacterianos/administración & dosificación , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Ascariasis/tratamiento farmacológico , Ascariasis/veterinaria , Ascaris suum/efectos de los fármacos , Heces/parasitología , Femenino , Intestinos/parasitología , Macrólidos , Masculino , Metastrongyloidea/efectos de los fármacos , Infecciones por Nematodos/tratamiento farmacológico , Esofagostomiasis/tratamiento farmacológico , Esofagostomiasis/veterinaria , Oesophagostomum/efectos de los fármacos , Recuento de Huevos de Parásitos/veterinaria , Distribución Aleatoria , Estómago/parasitología , Infecciones por Strongylida/tratamiento farmacológico , Infecciones por Strongylida/veterinaria , Porcinos , Enfermedades de los Porcinos/parasitología , Tricuriasis/tratamiento farmacológico , Tricuriasis/veterinaria , Trichuris/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA